ZYDUSLIFE Zydus Lifesciences Ltd Disruption of operations due to natural disasters, accidents, or other events Announcement 2023 - USFDA Approval Zydus Lifesciences Ltd has received final approval from the USFDA for Erythromycin Tablets USP, 250 mg and 500 mg..Find Corporate Announcements for Press Releases, AGM, Insider Trading & SAST, Results and Corporate Action for Zydus Lifesciences Ltd